Enzyme–substrate reporters for evaluation of substrate specificity of HIF prolyl hydroxylase isoforms


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

An organism naturally responds to hypoxia via stabilization of hypoxia-inducible factor (HIF). There are three isoforms of HIFα subunits whose stability is regulated by three isozymes of HIF prolyl hydroxylase (PHD1-3). Despite intense studies on recombinant enzyme isoforms using homogeneous activity assay, there is no consensus on the PHD iso-form preference for the HIF isoform as a substrate. This work provides a new approach to the problem of substrate specificity using cell-based reporters expressing the enzyme and luciferase-labeled substrate pair encoded in the same expression vector. The cell is used as a microbioreactor for running the reaction between the overexpressed enzyme and substrate. Using this novel approach, no PHD3 activity toward HIF3 was demonstrated, indirectly pointing to the hydroxylation of the second proline in 564PYIP567 (HIF1) catalyzed by this isozyme. The use of “paired” enzyme–substrate reporters to evaluate the potency of “branched tail” oxyquinoline inhibitors of HIF PHD allows higher precision in revealing the optimal structural motif for each enzyme isoform.

Sobre autores

A. Osipyants

Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology

Email: igazaryan@gmail.com
Rússia, Moscow, 117997

N. Smirnova

Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology

Email: igazaryan@gmail.com
Rússia, Moscow, 117997

A. Khristichenko

Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology

Email: igazaryan@gmail.com
Rússia, Moscow, 117997

D. Hushpulian

Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology

Email: igazaryan@gmail.com
Rússia, Moscow, 117997

S. Nikulin

Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology

Email: igazaryan@gmail.com
Rússia, Moscow, 117997

T. Chubar

Lomonosov Moscow State University, Chemistry Faculty

Email: igazaryan@gmail.com
Rússia, Moscow, 119991

A. Zakhariants

Innovations and High Technologies MSU Ltd.

Email: igazaryan@gmail.com
Rússia, Moscow, 109451

V. Tishkov

Lomonosov Moscow State University, Chemistry Faculty; Innovations and High Technologies MSU Ltd.

Email: igazaryan@gmail.com
Rússia, Moscow, 119991; Moscow, 109451

I. Gazaryan

Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology; Lomonosov Moscow State University, Chemistry Faculty

Autor responsável pela correspondência
Email: igazaryan@gmail.com
Rússia, Moscow, 117997; Moscow, 119991

A. Poloznikov

Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology

Email: igazaryan@gmail.com
Rússia, Moscow, 117997


Declaração de direitos autorais © Pleiades Publishing, Ltd., 2017

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies